523 related articles for article (PubMed ID: 34238294)
1. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
2. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Jiang H; Liu Y; Guo H; Liu Z; Li Z
BMC Cardiovasc Disord; 2024 May; 24(1):234. PubMed ID: 38702615
[TBL] [Abstract][Full Text] [Related]
3. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
4. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
Xie F; Yu Z; Xiong Y; Wu Z; Wu Y
Eur J Med Res; 2024 Feb; 29(1):145. PubMed ID: 38409069
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
[TBL] [Abstract][Full Text] [Related]
9. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
11. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
[TBL] [Abstract][Full Text] [Related]
12. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study.
Jiao Y; Su Y; Shen J; Hou X; Li Y; Wang J; Liu B; Qiu D; Sun Z; Chen Y; Xi Q; Shen M; Fu Z
Cardiovasc Diabetol; 2022 Jan; 21(1):3. PubMed ID: 34991602
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
15. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.
Zhu Y; Chen M; Liu K; Gao A; Kong X; Liu Y; Han H; Li H; Zhu H; Zhang J; Zhao Y
J Atheroscler Thromb; 2022 Aug; 29(8):1226-1235. PubMed ID: 34497172
[TBL] [Abstract][Full Text] [Related]
16. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
Zeng M; Yan X; Wu W
BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
[TBL] [Abstract][Full Text] [Related]
18. Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
Zhao Q; Cheng YJ; Xu YK; Zhao ZW; Liu C; Sun TN; Zhou YJ
Cardiovasc Diabetol; 2021 Sep; 20(1):190. PubMed ID: 34537077
[TBL] [Abstract][Full Text] [Related]
19. Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies.
Gil RJ; Bil J; Kern A; Iñigo-Garcia LA; Formuszewicz R; Dobrzycki S; Vassilev D; Mehran R
Cardiovasc Ther; 2020; 2020():6760205. PubMed ID: 32411301
[TBL] [Abstract][Full Text] [Related]
20. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]